Valuation: Repligen Corporation

Market Cap 11.39B 10.15B 9.31B 8.46B 15.9B 1,077B 16.27B 111B 44.6B 570B 42.76B 41.84B 1,805B P/E 2026 *
-536x
P/E 2027 * 126x
Enterprise Value 10.58B 9.43B 8.65B 7.86B 14.77B 1T 15.11B 103B 41.43B 529B 39.71B 38.86B 1,676B EV / Sales 2026 *
12.5x
EV / Sales 2027 * 9.69x
Free-Float
94.98%
Yield 2026 *
-
Yield 2027 * -
1 day-0.04%
1 week-3.51%
Current month+0.71%
1 month-1.93%
3 months+18.97%
6 months+50.75%
Current year+8.75%
1 week 171.23
Extreme 171.23
188.5
1 month 157.44
Extreme 157.4355
194.36
Current year 100.99
Extreme 100.99
198.87
1 year 100.99
Extreme 100.99
198.87
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
300.23
10 years 26.61
Extreme 26.61
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Director/Board Member 61 2020-02-29
Date Insider Type Main position Quantity % Market Cap. Importance
10/6/26 Free

Executive/Senior Manager

1,375 0.0024%
10/5/26 Sell

Chief Executive Officer

-13,939 0.0247%
10/2/26 Tax

Chief Executive Officer

-1,248 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-0.04%-3.51%+21.28%+18.52% 11.39B
+5.59%+12.54%-8.18%+20.52% 200B
+6.15%+10.74%+16.08%+44.65% 128B
+9.37%+11.73%-6.33%+22.96% 129B
+0.79%+6.93%-39.76%+10.36% 97.53B
+3.96%+9.14%+2.75%+81.38% 67.55B
+5.56%+7.19%+16.84%-19.20% 56.98B
+3.94%+24.10%-3.26%+62.72% 55.04B
-1.39%-8.56%-2.92%+53.39% 51.24B
-1.03%+6.47%+4.55%-6.18% 37.43B
Average +2.64%+7.61%+0.10%+28.91% 83.48B
Weighted average by Cap. +3.66%+9.60%-3.64%+29.22%

Financials

2026 *2027 *
Net sales 849M 756M 694M 630M 1.19B 80.22B 1.21B 8.29B 3.32B 42.46B 3.19B 3.12B 134B 1.07B 953M 874M 795M 1.49B 101B 1.53B 10.45B 4.19B 53.52B 4.02B 3.93B 170B
Net income -19.07M -17M -15.59M -14.16M -26.63M -1.8B -27.24M -186M -74.68M -954M -71.59M -70.06M -3.02B 87.5M 77.97M 71.51M 64.98M 122M 8.27B 125M 855M 343M 4.38B 328M 321M 13.86B
Net Debt -811M -723M -663M -602M -1.13B -76.64B -1.16B -7.92B -3.18B -40.56B -3.04B -2.98B -128B -1.02B -910M -835M -759M -1.43B -96.56B -1.46B -9.98B -4B -51.11B -3.84B -3.75B -162B
Projected Income Statement - Annual - Repligen Corporation
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-11-04 US$178.20 -0.04% 1,058,141
26-11-03 US$178.27 +3.08% 1,019,569
26-11-02 US$172.95 -2.26% 1,576,336
26-10-30 US$176.94 -6.20% 4,472,065
26-10-29 US$188.64 +2.14% 890,266
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Repligen Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
178.20USD
Average target price
203.45USD
Spread / Average Target
+14.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Repligen Corporation
  1. Stock Market
  2. Stocks
  3. RGEN Stock